
May 15, 2008 - Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute » Read
January 31, 2008 - Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors » Read
January 30, 2008 - Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors » Read
|